The Efficacy and Safety of Neoadjuvant Trastuzumab Plus Taxane With and Without Pertuzumab Therapy

UnknownOBSERVATIONAL
Enrollment

1,500

Participants

Timeline

Start Date

April 29, 2021

Primary Completion Date

November 15, 2021

Study Completion Date

November 15, 2021

Conditions
Breast Cancer
Trial Locations (1)

Unknown

RECRUITING

Medipol University Medical Faculty, Istanbul

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Medipol University

OTHER

collaborator

Bezmialem Vakif University

OTHER

collaborator

Koç University

OTHER

collaborator

Medical Park AG

INDUSTRY

collaborator

Uludag University

OTHER

collaborator

Akdeniz University

OTHER

collaborator

Dicle University

OTHER

collaborator

Trakya University

OTHER

collaborator

Ankara City Hospital Bilkent

OTHER

collaborator

Memorial Ankara Hospital

OTHER

collaborator

Gulhane Training and Research Hospital

OTHER_GOV

collaborator

Liv Hospital Ankara

OTHER

collaborator

Ankara University

OTHER

collaborator

Istanbul Medeniyet University

OTHER

collaborator

Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital

OTHER

collaborator

Acıbadem Atunizade Hospital

OTHER

collaborator

Inonu University

OTHER

collaborator

Ege University

OTHER

lead

Ahmet Bilici

OTHER